Legend Biotech Corp. (LEGN)
17.86
+0.06
(+0.34%)
USD |
NASDAQ |
Oct 13, 16:00
17.86
0.00 (0.00%)
After-Hours: 17:31
Legend Biotech Free Cash Flow (Quarterly) : -41.49M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -41.49M |
| March 31, 2026 | -111.33M |
| December 31, 2025 | -126.56M |
| September 30, 2025 | 15.22M |
| June 30, 2025 | -28.93M |
| March 31, 2025 | -121.11M |
| December 31, 2024 | -90.21M |
| September 30, 2024 | -92.53M |
| June 30, 2024 | -20.97M |
| March 31, 2024 | -6.605M |
| December 31, 2023 | -118.65M |
| September 30, 2023 | -91.16M |
| June 30, 2023 | -91.69M |
| March 31, 2023 | -141.05M |
| Date | Value |
|---|---|
| December 31, 2022 | -63.27M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -78.69M |
| December 31, 2021 | -71.71M |
| September 30, 2021 | -57.00M |
| June 30, 2021 | -60.09M |
| March 31, 2021 | -26.74M |
| December 31, 2020 | -56.16M |
| September 30, 2020 | -64.38M |
| June 30, 2020 | -56.88M |
| March 31, 2020 | -61.18M |
| December 31, 2019 | -59.99M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 3.433B |
| Ionis Pharmaceuticals, Inc. | 547.30M |
| Johnson & Johnson | 7.295B |
| Arbutus Biopharma Corp. | -5.952M |
| Capricor Therapeutics, Inc. | -37.39M |